Alaggio R, Amador C, Anagnostopoulos I, et al. The 5 th edition of the World Health Organization classification of haematolymphoid tumours: lymphoid neoplasms. Leukemia. 2022;36:1720–48.

Article  PubMed  PubMed Central  Google Scholar 

Swerdlow SH, Campo E, Harris NL, et al. World Health Organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues, revised. 4th ed. Lyon: IARC Press; 2017.

Google Scholar 

Campo E, Jaffe ES, Cook JR, et al. The international consensus classification of mature lymphoid neoplasms: a report from the clinical advisory committee. Blood. 2022;140:1229–53.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Harris NL, Jaffe ES, Stein H, et al. A revised European-American classification of lymphoid neoplasms: a proposal from the international lymphoma study group. Blood. 1994;84:1361–92.

Article  CAS  PubMed  Google Scholar 

Falini B, Lazzi S, Pileri S. A comparison of the international consensus and 5th WHO classifications of T-cell lymphomas and histiocytic/dendritic cell tumours. Br J Haematol. 2023. https://doi.org/10.1111/bjh.18940.

Article  PubMed  Google Scholar 

Falini B, Martino G, Lazzi S. A comparison of the International Consensus and 5th World Health Organization classifications of mature B-cell lymphomas. Leukemia. 2023;37:18–34.

Article  PubMed  Google Scholar 

Vela V, Juskevicius D, Dirnhofer S, Menter T, Tzankov A. Mutational landscape of marginal zone B-cell lymphomas of various origin: organotypic alterations and diagnostic potential for assignment of organ origin. Virchows Arch. 2022;480:403–13.

Article  CAS  PubMed  Google Scholar 

Brenner I, Roth S, Puppe B, Wobser M, Rosenwald A, Geissinger E. Primary cutaneous marginal zone lymphomas with plasmacytic differentiation show frequent IgG4 expression. Mod Pathol. 2013;26:1568–76.

Article  CAS  PubMed  Google Scholar 

Bende RJ, Aarts WM, Riedl RG, de Jong D, Pals ST, van Noesel CJ. Among B cell non-Hodgkin’s lymphomas, MALT lymphomas express a unique antibody repertoire with frequent rheumatoid factor reactivity. J Exp Med. 2005;201:1229–41.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Maurus K, Appenzeller S, Roth S, et al. Panel sequencing shows recurrent genetic FAS alterations in primary cutaneous marginal zone lymphoma. J Invest Dermatol. 2018;138:1573–81.

Article  CAS  PubMed  Google Scholar 

Edinger JT, Kant JA, Swerdlow SH. Cutaneous marginal zone lymphomas have distinctive features and include 2 subsets. Am J Surg Pathol. 2010;34:1830–41.

Article  PubMed  Google Scholar 

Streilein JW, Alard P, Niizeki H. A new concept of skin-associated lymphoid tissue (SALT): UVB light impaired cutaneous immunity reveals a prominent role for cutaneous nerves. Keio J Med. 1999;48:22–7.

Article  CAS  PubMed  Google Scholar 

Randen U, Troen G, Tierens A, et al. Primary cold agglutinin-associated lymphoproliferative disease: a B-cell lymphoma of the bone marrow distinct from lymphoplasmacytic lymphoma. Haematologica. 2014;99:497–504.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malecka A, Delabie J, Ostlie I, et al. Cold agglutinin-associated B-cell lymphoproliferative disease shows highly recurrent gains of chromosome 3 and 12 or 18. Blood Adv. 2020;4:993–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Malecka A, Troen G, Tierens A, et al. Frequent somatic mutations of KMT2D (MLL2) and CARD11 genes in primary cold agglutinin disease. Br J Haematol. 2018;183:838–42.

Article  CAS  PubMed  Google Scholar 

Ascoli V, Lo Coco F, Torelli G, et al. Human herpesvirus 8-associated primary effusion lymphoma in HIV–patients: a clinicopidemiologic variant resembling classic Kaposi’s sarcoma. Haematologica. 2002;87:339–43.

PubMed  Google Scholar 

Kaji D, Ota Y, Sato Y, et al. Primary human herpesvirus 8-negative effusion-based lymphoma: a large B-cell lymphoma with favorable prognosis. Blood Adv. 2020;4:4442–50.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Marafioti T, Jones M, Facchetti F, et al. Phenotype and genotype of interfollicular large B cells, a subpopulation of lymphocytes often with dendritic morphology. Blood. 2003;102:2868–76.

Article  CAS  PubMed  Google Scholar 

Traverse-Glehen A, Pittaluga S, Gaulard P, et al. Mediastinal gray zone lymphoma: the missing link between classic Hodgkin’s lymphoma and mediastinal large B-cell lymphoma. Am J Surg Pathol. 2005;29:1411–21.

Article  PubMed  Google Scholar 

Sarkozy C, Hung SS, Chavez EA, et al. Mutational landscape of gray zone lymphoma. Blood. 2021;137:1765–76.

Article  CAS  PubMed  Google Scholar 

Zhan F, Huang Y, Colla S, et al. The molecular classification of multiple myeloma. Blood. 2006;108:2020–8.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Fonseca R, Bergsagel PL, Drach J, et al. International Myeloma Working Group molecular classification of multiple myeloma: spotlight review. Leukemia. 2009;23:2210–21.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Corre J, Munshi N, Avet-Loiseau H. Genetics of multiple myeloma: another heterogeneity level? Blood. 2015;125:1870–6.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Swerdlow S, Campo E, Harris N, et al. world health organization classification of tumours: pathology and genetics of tumours of haematopoietic and lymphoid tissues. 4th ed. Lyon: IARC Press; 2008.

Google Scholar 

Vaux DL, Cory S, Adams JM. Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature. 1988;335:440–2.

Article  CAS  PubMed  Google Scholar 

Strasser A, Harris AW, Bath ML, Cory S. Novel primitive lymphoid tumours induced in transgenic mice by cooperation between myc and bcl-2. Nature. 1990;348:331–3.

Article  CAS  PubMed  Google Scholar 

Johnson NA, Savage KJ, Ludkovski O, et al. Lymphomas with concurrent BCL2 and MYC translocations: the critical factors associated with survival. Blood. 2009;114:2273–9.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Niitsu N, Okamoto M, Miura I, Hirano M. Clinical features and prognosis of de novo diffuse large B-cell lymphoma with t(14;18) and 8q24/c-MYC translocations. Leukemia. 2009;23:777–83.

Article  CAS  PubMed  Google Scholar 

Moore EM, Aggarwal N, Surti U, Swerdlow SH. Further exploration of the complexities of large B-cell lymphomas with MYC abnormalities and the importance of a blastoid morphology. Am J Surg Pathol. 2017;41:1155–66.

Article  PubMed  Google Scholar 

Kanagal-Shamanna R, Medeiros LJ, Lu G, et al. High-grade B cell lymphoma, unclassifiable, with blastoid features: an unusual morphological subgroup associated frequently with BCL2 and/or MYC gene rearrangements and a poor prognosis. Histopathology. 2012;61:945–54.

Article  PubMed  Google Scholar 

Pillai RK, Sathanoori M, Van Oss SB, Swerdlow SH. Double-hit B-cell lymphomas with BCL6 and MYC translocations are aggressive, frequently extranodal lymphomas distinct from BCL2 double-hit B-cell lymphomas. Am J Surg Pathol. 2013;37:323–32.

Article  PubMed  Google Scholar 

Ye Q, Xu-Monette ZY, Tzankov A, et al. Prognostic impact of concurrent MYC and BCL6 rearrangements and expression in de novo diffuse large B-cell lymphoma. Oncotarget. 2016;7:2401–16.

Article  PubMed  Google Scholar 

Cucco F, Barrans S, Sha C, et al. Distinct genetic changes reveal evolutionary history and heterogeneous molecular grade of DLBCL with MYC/BCL2 double-hit. Leukemia. 2020;34:1329–41.

Article  CAS  PubMed  Google Scholar 

Guo Y, Karube K, Kawano R, et al. Low-grade follicular lymphoma with t(14;18) presents a homogeneous disease entity otherwise the rest comprises minor groups of heterogeneous disease entities with Bcl2 amplification, Bcl6 translocation or other gene aberrances. Leukemia. 2005;19:1058–63.

Article  CAS  PubMed  Google Scholar 

Koch K, Hoster E, Ziepert M, et al. Clinical, pathological and genetic features of follicular lymphoma grade 3A: a joint analysis of the German low-grade and high-grade lymphoma study groups GLSG and DSHNHL. Ann Oncol. 2016;27:1323–9.

Article  CAS  PubMed  Google Scholar 

El Behery R, Laurini JA, Weisenburger DD, et al. Follicular large cleaved cell (centrocytic) lymphoma: an unrecognized variant of follicular lymphoma. Hum Pathol. 2018;72:180–90.

Article  PubMed  Google Scholar 

Laurent C, Adelaide J, Guille A, et al. High-grade follicular lymphomas exhibit clinicopathologic, cytogenetic, and molecular diversity extending beyond grades 3A and 3B. Am J Surg Pathol. 2021;45:1324–36.

Article  PubMed  Google Scholar